Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Study of REGENERA Implant in Malignant Breast Lesion Treated by Lumpectomy

NCT05941299 is registered in ClinicalTrials.gov with Tensive SRL as lead sponsor.

NCT NCT05941299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05941299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Study of REGENERA Implant in Malignant Breast Lesion Treated by Lumpectomy
Lead sponsor
Tensive SRL
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 29, 2023
Completion date
December 30, 2029
Enrollment
92 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm malignant female, mastectomy, segmental